Sentences with phrase «growth stocks increases»

The rich investment in growth stocks increases risk associated with these types of funds.

Dividend growth stocks increase their dividends on a regular basis — as their name implies — because of the growth in revenue and earnings.

Good dividend growth stocks increase their dividends on an annual basis providing you with more cash

Not exact matches

«Growth» stocks are often considered those whose earnings are expected to increase at an above - average rate but don't necessarily boast the same strong fundamental backdrop.

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

Still, the Fed chairman reiterated his argument that lower rates boost growth by helping increase prices of stocks, homes and other assets.

A report from CIBC World Markets recently predicted the stock market might fall 10 % — 15 % this summer due to a confluence of factors, including a weak U.S. housing market, increasing fiscal strain, expensive oil prices, sluggish corporate earnings growth and disruptions in global supply chains stemming from the Japanese crisis.

Economic growth well above expectations could be an issue for stocks because it increases the chances the Fed will suddenly get more aggressive on rate hikes.

Tom Wynn, director of affluent research at Spectrem, provided several factors for the increased confidence: the steady improvement in job growth, the steady increase in the major stock market indices since the spring, and a decrease in political ambiguity with the election season over, which has an effect on at least some people's outlook.

According to Panera, the growth in the MyPanera program has allowed the company to significantly increase the efficiency of its marketing, and perhaps not coincidentally, over the past year, the company's stock price has increased almost 30 percent.

China's stock market woes are ongoing, and there's an increasing sense that China's gaudy annual growth rates are misleading exaggerations of the country's actual economic state.

«Shopify's stock price is perched on the halo of increased merchant count, which all of the growth and the bulk of the numbers is from the «entrepreneur count,»» Left explained.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

At the point the growth began to slow, the multiple would contract, meaning that even if its earnings do grow 600 % in the next few years, if it becomes subject to the law of big numbers - that ever increasing amounts eventually forge their own anchor - the result would be a market capitalization substantially similar to today, leading to no increase in the stock price over a long period of time.

The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, revenue growth, notable return on equity and solid stock price performance.

Sam, again this is my opinion, but I think you have done a great job creating a Real estate empire, my empire relies on stocks investing in the greatest dividend growth companies in the world that have continued paying increasing dividends year after year.

This ratio means the market expects the after - tax profits (NOPAT) of XLF stocks to increase 40 % from current levels while KIE stocks are priced for expectations of 10 % NOPAT growth from current levels.

For example, our equity philosophy is to seek out companies that increase their dividend regularly — referred to as dividend growth stocks.

Since investors can't quickly change the long - term growth rate of earnings, the only way to substantially increase the long - term rate of return offered by stocks is to lower prices vertically.

While the lack of revenue growth is disappointing, I like that the company is aggressively buying back stock, cutting costs, and increasing margins in order to continue growing profits.

Capital Appreciation Fund - A mutual fund attempting to increase the asset value utilizing the investments in growth stocks.

The telecom company continued to show solid share - net growth in the December quarter, supported by stock buybacks, good cost management, wireless margin improvement, and increased penetration of U-verse, its broadband, video, and IP telephone service.

You can then increase the portion in ETFs if you wish a more conservative portfolio or simply ignore the last few lines and concentrate on the stocks if you seek more growth than revenues.

Important factors that may affect the Company's business and operations and that may cause actual results to differ materially from those in the forward - looking statements include, but are not limited to, increased competition; the Company's ability to maintain, extend and expand its reputation and brand image; the Company's ability to differentiate its products from other brands; the consolidation of retail customers; the Company's ability to predict, identify and interpret changes in consumer preferences and demand; the Company's ability to drive revenue growth in its key product categories, increase its market share, or add products; an impairment of the carrying value of goodwill or other indefinite - lived intangible assets; volatility in commodity, energy and other input costs; changes in the Company's management team or other key personnel; the Company's inability to realize the anticipated benefits from the Company's cost savings initiatives; changes in relationships with significant customers and suppliers; execution of the Company's international expansion strategy; changes in laws and regulations; legal claims or other regulatory enforcement actions; product recalls or product liability claims; unanticipated business disruptions; failure to successfully integrate the Company; the Company's ability to complete or realize the benefits from potential and completed acquisitions, alliances, divestitures or joint ventures; economic and political conditions in the nations in which the Company operates; the volatility of capital markets; increased pension, labor and people - related expenses; volatility in the market value of all or a portion of the derivatives that the Company uses; exchange rate fluctuations; disruptions in information technology networks and systems; the Company's inability to protect intellectual property rights; impacts of natural events in the locations in which the Company or its customers, suppliers or regulators operate; the Company's indebtedness and ability to pay such indebtedness; the Company's dividend payments on its Series A Preferred Stock; tax law changes or interpretations; pricing actions; and other factors.

Many utilities and even Coca Cola looks like a growth stock the last 10 years with 108 % increase.

NEW YORK (TheStreet)-- Yamana Gold (AUY) stock is gaining by 1.81 % to $ 2.24 in afternoon trading on Wednesday, after gold prices increased as worries over global growth weighed on the dollar.

He served as Director of Markets at the London Stock Exchange PLC (LSE) and Head of its Alternative Investment Market (AIM), where he led the exchange's transformational growth strategy focused on driving market efficiency and resulting in a fivefold increase in market size.

Important factors that may affect the Company's business and operations and that may cause actual results to differ materially from those in the forward - looking statements include, but are not limited to, operating in a highly competitive industry; changes in the retail landscape or the loss of key retail customers; the Company's ability to maintain, extend and expand its reputation and brand image; the impacts of the Company's international operations; the Company's ability to leverage its brand value; the Company's ability to predict, identify and interpret changes in consumer preferences and demand; the Company's ability to drive revenue growth in its key product categories, increase its market share, or add products; an impairment of the carrying value of goodwill or other indefinite - lived intangible assets; volatility in commodity, energy and other input costs; changes in the Company's management team or other key personnel; the Company's ability to realize the anticipated benefits from its cost savings initiatives; changes in relationships with significant customers and suppliers; the execution of the Company's international expansion strategy; tax law changes or interpretations; legal claims or other regulatory enforcement actions; product recalls or product liability claims; unanticipated business disruptions; the Company's ability to complete or realize the benefits from potential and completed acquisitions, alliances, divestitures or joint ventures; economic and political conditions in the United States and in various other nations in which we operate; the volatility of capital markets; increased pension, labor and people - related expenses; volatility in the market value of all or a portion of the derivatives we use; exchange rate fluctuations; risks associated with information technology and systems, including service interruptions, misappropriation of data or breaches of security; the Company's ability to protect intellectual property rights; impacts of natural events in the locations in which we or the Company's customers, suppliers or regulators operate; the Company's indebtedness and ability to pay such indebtedness; the Company's ownership structure; the impact of future sales of its common stock in the public markets; the Company's ability to continue to pay a regular dividend; changes in laws and regulations; restatements of the Company's consolidated financial statements; and other factors.

We determined that an increase in the aggregate equity value consistent with a required rate of return was appropriate considering our rapid growth and developments since the date of the Series G convertible preferred stock financing.

Shares of growth stocks do better when the economy is growing quickly, when interest rates are lower and when investor sentiment is increasing.

On the other hand, stock prices are — to a certain extent — a function of earnings growth, and smaller companies are often able to increase their profits at a faster speed than larger businesses.

When an investor wants to increase the stability and long - term steady growth of a portfolio, investing in blue chip stocks is common.

Possible explanations for these trends: creation of many small growth companies; tax considerations; and, use of stock repurchases in lieu of dividends or dividend increases.

The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, increase in stock price during the past year and expanding profit margins.

I'd put 75 % of assets into higher growth buy - and - hold - forever stocks like Brown Forman, Colgate - Palmolive, Hershey, and Nike, and then the remaining 25 % into Fisherified value stocks like DineEquity during the 2010 through 2015 stretch when it was cheap at the beginning of the period while simultaneously increasing its intrinsic value due to the receipt of significant one - time franchise fees.

The rise in payments on debt is consistent with the growth in the stock of Australian foreign debt, while the increase in payments on equity coincides with a period of strong growth in Australian corporate profitability.

At the same time, stock analysts have continued to increase their estimates for earnings growth.

It is likely that growth in sales to the Asian region will increase as businesses in those countries meet further increases in demand by boosting production rather than running down stocks.

While the company's five consecutive years of dividend increases is a bit shorter of a track record than I'd typically like to see, the dividend growth has been tremendous: the stock's three - year dividend growth rate is sitting at 44.2 %.

With China's increasing domestic demand for gold, economic growth trends and continued weakness in the Chinese stock market, some analysts expect gold prices to reach new highs.

«Dividend Growth Investing is about purchasing dividend - paying stocks that grow their dividends over time, and then holding onto those investments for quite a while as you receive continually increasing passive income from those companies..»

Unlike gold mining, growth in the number of computers «mining» bitcoin does not increase the rate at which the total stock of bitcoin grows.

Not surprisingly, stocks that have been able to increase their dividends for such a long period of time often have very durable businesses, have exhibited earnings growth, and have done quite well compared to the market.

This lack of pricing power could negatively impact future sales growth, and could become an increasing discomfort for a market that has known only quarter after quarter of rising stock prices.

Since I wrote about BNCC.pk, a lot has changed with the company: the stock price has nearly quintupled, the assets and equity have both skyrocketed, and the company has been increasing earnings at unfathomable rates (year - over-year earnings growth was 505 %).

Does that mean that stocks generally have growth rates > inflation or that stocks will roughly also increase by an additional amount due to inflation (roughly):

Against this backdrop, we like U.S. companies able to increase revenues and earnings in a low - growth world, such as selected technology stocks.

A growth stock is a company stock that tends to increase in capital value rather than high yield income.

For a stock trading at 10x earnings, this would increase earnings per share (EPS) by 10 % plus the organic growth of 3 %, leaving the investor compounding at roughly 13 %.

From the demand side, this year's growth was driven in significant part by a more than $ 6 trillion increase in household wealth from the stock market rally.